 Muhammad Aftab
Concepts (263)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Aorta, Thoracic | 19 | 2025 | 262 | 4.040 |
Why?
| | Cardiac Surgical Procedures | 14 | 2023 | 499 | 3.430 |
Why?
| | Aortic Aneurysm, Thoracic | 14 | 2022 | 127 | 3.430 |
Why?
| | Blood Vessel Prosthesis Implantation | 12 | 2024 | 198 | 2.510 |
Why?
| | Postoperative Complications | 14 | 2025 | 2479 | 2.390 |
Why?
| | Aortic Aneurysm | 5 | 2020 | 65 | 1.900 |
Why?
| | Hospital Mortality | 13 | 2020 | 850 | 1.830 |
Why?
| | Cardiopulmonary Bypass | 6 | 2020 | 202 | 1.790 |
Why?
| | Circulatory Arrest, Deep Hypothermia Induced | 4 | 2022 | 25 | 1.470 |
Why?
| | Spinal Cord Ischemia | 8 | 2022 | 56 | 1.240 |
Why?
| | Loeys-Dietz Syndrome | 2 | 2019 | 6 | 1.240 |
Why?
| | Endovascular Procedures | 7 | 2018 | 301 | 1.230 |
Why?
| | Thrombocytopenia | 2 | 2020 | 186 | 1.150 |
Why?
| | Acute Kidney Injury | 5 | 2025 | 790 | 1.080 |
Why?
| | Heart Valve Prosthesis Implantation | 4 | 2017 | 177 | 1.070 |
Why?
| | Aortic Valve | 8 | 2020 | 348 | 1.060 |
Why?
| | Spinal Cord | 6 | 2019 | 356 | 1.010 |
Why?
| | Vascular Surgical Procedures | 4 | 2019 | 294 | 1.010 |
Why?
| | Paraplegia | 5 | 2022 | 57 | 0.960 |
Why?
| | Heart Transplantation | 6 | 2023 | 721 | 0.950 |
Why?
| | Thoracic Surgery | 8 | 2020 | 122 | 0.920 |
Why?
| | Heart Valve Diseases | 4 | 2020 | 151 | 0.910 |
Why?
| | Spinal Cord Injuries | 4 | 2021 | 194 | 0.900 |
Why?
| | Intraoperative Neurophysiological Monitoring | 2 | 2021 | 21 | 0.850 |
Why?
| | Aorta | 7 | 2019 | 411 | 0.840 |
Why?
| | Shock, Cardiogenic | 2 | 2020 | 59 | 0.780 |
Why?
| | Extracorporeal Membrane Oxygenation | 3 | 2020 | 282 | 0.750 |
Why?
| | Dissection | 3 | 2020 | 51 | 0.740 |
Why?
| | Blood Transfusion | 2 | 2020 | 296 | 0.700 |
Why?
| | Kidney Failure, Chronic | 3 | 2025 | 547 | 0.680 |
Why?
| | Diazoxide | 5 | 2021 | 23 | 0.670 |
Why?
| | Aortitis | 1 | 2019 | 10 | 0.650 |
Why?
| | Spinal Cord Stimulation | 1 | 2019 | 8 | 0.630 |
Why?
| | Politics | 1 | 2020 | 93 | 0.630 |
Why?
| | Perfusion | 3 | 2022 | 197 | 0.620 |
Why?
| | Humans | 70 | 2025 | 129385 | 0.620 |
Why?
| | Aortic Valve Insufficiency | 1 | 2018 | 46 | 0.610 |
Why?
| | Creatinine | 1 | 2020 | 490 | 0.590 |
Why?
| | Stroke | 4 | 2024 | 1067 | 0.580 |
Why?
| | Middle Aged | 30 | 2025 | 31102 | 0.580 |
Why?
| | Ochronosis | 1 | 2017 | 1 | 0.570 |
Why?
| | Alkaptonuria | 1 | 2017 | 2 | 0.570 |
Why?
| | Erythropoietin | 4 | 2018 | 86 | 0.560 |
Why?
| | Length of Stay | 6 | 2020 | 1124 | 0.560 |
Why?
| | Retrospective Studies | 23 | 2025 | 14498 | 0.520 |
Why?
| | Oral Submucous Fibrosis | 1 | 2016 | 2 | 0.520 |
Why?
| | Treatment Outcome | 18 | 2022 | 10195 | 0.520 |
Why?
| | Intraoperative Complications | 1 | 2017 | 130 | 0.510 |
Why?
| | Heart Diseases | 1 | 2019 | 350 | 0.490 |
Why?
| | Mouth Mucosa | 1 | 2016 | 89 | 0.490 |
Why?
| | Cardiomyopathies | 1 | 2019 | 337 | 0.480 |
Why?
| | Aged | 21 | 2025 | 22052 | 0.470 |
Why?
| | Internship and Residency | 7 | 2020 | 1050 | 0.460 |
Why?
| | Aortic Rupture | 1 | 2014 | 25 | 0.460 |
Why?
| | Viscera | 1 | 2014 | 16 | 0.460 |
Why?
| | Career Choice | 5 | 2016 | 207 | 0.460 |
Why?
| | Aortic Valve Stenosis | 1 | 2017 | 218 | 0.450 |
Why?
| | Risk Assessment | 10 | 2024 | 3236 | 0.450 |
Why?
| | Male | 41 | 2025 | 63597 | 0.450 |
Why?
| | Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2018 | 430 | 0.450 |
Why?
| | Ischemia | 3 | 2021 | 406 | 0.430 |
Why?
| | Prognosis | 7 | 2020 | 3791 | 0.420 |
Why?
| | Reperfusion Injury | 3 | 2021 | 272 | 0.420 |
Why?
| | Time Factors | 11 | 2020 | 6550 | 0.420 |
Why?
| | Anti-Inflammatory Agents, Non-Steroidal | 1 | 2016 | 337 | 0.410 |
Why?
| | Female | 34 | 2025 | 68693 | 0.400 |
Why?
| | Incidence | 4 | 2020 | 2641 | 0.390 |
Why?
| | Coronary Artery Disease | 3 | 2025 | 679 | 0.370 |
Why?
| | Cardiovascular Diseases | 2 | 2023 | 2001 | 0.370 |
Why?
| | Patient Selection | 4 | 2019 | 662 | 0.350 |
Why?
| | Risk Factors | 12 | 2025 | 9752 | 0.340 |
Why?
| | Neurons | 2 | 2020 | 1511 | 0.320 |
Why?
| | Propensity Score | 3 | 2019 | 265 | 0.320 |
Why?
| | Hypothermia, Induced | 2 | 2022 | 76 | 0.320 |
Why?
| | Receptors, Erythropoietin | 2 | 2018 | 20 | 0.300 |
Why?
| | Cerebrovascular Circulation | 3 | 2022 | 226 | 0.280 |
Why?
| | Heart-Assist Devices | 3 | 2019 | 539 | 0.270 |
Why?
| | Comorbidity | 3 | 2020 | 1546 | 0.270 |
Why?
| | Kidney | 1 | 2014 | 1384 | 0.260 |
Why?
| | Aortic Diseases | 2 | 2019 | 115 | 0.260 |
Why?
| | Multivariate Analysis | 3 | 2020 | 1501 | 0.250 |
Why?
| | Adult | 20 | 2023 | 35514 | 0.250 |
Why?
| | Reoperation | 3 | 2018 | 544 | 0.240 |
Why?
| | Specialties, Surgical | 2 | 2016 | 73 | 0.240 |
Why?
| | Coronary Artery Bypass | 2 | 2025 | 222 | 0.240 |
Why?
| | Intensive Care Units | 2 | 2020 | 737 | 0.230 |
Why?
| | Elective Surgical Procedures | 1 | 2025 | 165 | 0.220 |
Why?
| | Organ Preservation Solutions | 1 | 2023 | 45 | 0.220 |
Why?
| | Primary Graft Dysfunction | 1 | 2023 | 29 | 0.210 |
Why?
| | Anastomosis, Surgical | 3 | 2019 | 149 | 0.210 |
Why?
| | Follow-Up Studies | 4 | 2019 | 4888 | 0.200 |
Why?
| | Kaplan-Meier Estimate | 4 | 2019 | 857 | 0.200 |
Why?
| | Heart Valve Prosthesis | 1 | 2023 | 112 | 0.190 |
Why?
| | Replantation | 2 | 2018 | 31 | 0.190 |
Why?
| | Education, Medical, Graduate | 2 | 2016 | 437 | 0.180 |
Why?
| | Tissue and Organ Procurement | 2 | 2022 | 288 | 0.180 |
Why?
| | Survival Rate | 4 | 2019 | 1874 | 0.180 |
Why?
| | Surgeons | 2 | 2023 | 259 | 0.180 |
Why?
| | Stents | 3 | 2022 | 504 | 0.180 |
Why?
| | Vascular Grafting | 1 | 2020 | 13 | 0.180 |
Why?
| | Surveys and Questionnaires | 7 | 2020 | 5390 | 0.180 |
Why?
| | Minimally Invasive Surgical Procedures | 2 | 2019 | 170 | 0.170 |
Why?
| | Heart Arrest, Induced | 2 | 2017 | 31 | 0.170 |
Why?
| | Age Factors | 2 | 2020 | 3144 | 0.170 |
Why?
| | Cardiovascular Abnormalities | 1 | 2020 | 14 | 0.170 |
Why?
| | Subclavian Artery | 1 | 2020 | 27 | 0.170 |
Why?
| | Decision Support Techniques | 1 | 2024 | 396 | 0.170 |
Why?
| | Carotid Artery, Common | 1 | 2020 | 35 | 0.170 |
Why?
| | Beauty | 1 | 2020 | 19 | 0.170 |
Why?
| | Thoracic Surgery, Video-Assisted | 1 | 2020 | 43 | 0.170 |
Why?
| | Mice, Inbred C57BL | 6 | 2021 | 5440 | 0.170 |
Why?
| | Mitral Valve | 1 | 2020 | 85 | 0.160 |
Why?
| | United States | 8 | 2020 | 13876 | 0.160 |
Why?
| | Acidosis | 1 | 2020 | 89 | 0.160 |
Why?
| | Marfan Syndrome | 2 | 2017 | 40 | 0.160 |
Why?
| | Prosthesis Failure | 1 | 2020 | 114 | 0.160 |
Why?
| | Prosthesis-Related Infections | 1 | 2020 | 75 | 0.160 |
Why?
| | Ultrasonography, Interventional | 1 | 2020 | 128 | 0.160 |
Why?
| | Machine Learning | 1 | 2024 | 443 | 0.160 |
Why?
| | Morbidity | 1 | 2020 | 302 | 0.160 |
Why?
| | Heart Arrest | 1 | 2022 | 321 | 0.160 |
Why?
| | Pacemaker, Artificial | 1 | 2020 | 110 | 0.150 |
Why?
| | Sepsis | 1 | 2025 | 572 | 0.150 |
Why?
| | Postoperative Period | 1 | 2020 | 328 | 0.150 |
Why?
| | Device Removal | 1 | 2020 | 135 | 0.150 |
Why?
| | Age Distribution | 1 | 2019 | 372 | 0.150 |
Why?
| | Thrombectomy | 1 | 2019 | 59 | 0.150 |
Why?
| | Sex Distribution | 1 | 2019 | 359 | 0.150 |
Why?
| | Acute Disease | 3 | 2017 | 978 | 0.150 |
Why?
| | Early Diagnosis | 1 | 2020 | 234 | 0.150 |
Why?
| | Reimbursement Mechanisms | 1 | 2019 | 84 | 0.150 |
Why?
| | Nerve Growth Factor | 1 | 2018 | 27 | 0.150 |
Why?
| | Vena Cava, Inferior | 1 | 2019 | 68 | 0.150 |
Why?
| | Nervous System Diseases | 1 | 2021 | 252 | 0.150 |
Why?
| | Substance Abuse, Intravenous | 1 | 2019 | 108 | 0.150 |
Why?
| | Heart Atria | 1 | 2019 | 128 | 0.150 |
Why?
| | Databases, Factual | 2 | 2020 | 1269 | 0.150 |
Why?
| | Risk | 1 | 2020 | 854 | 0.140 |
Why?
| | Reactive Oxygen Species | 1 | 2020 | 596 | 0.140 |
Why?
| | Betacoronavirus | 1 | 2020 | 248 | 0.140 |
Why?
| | Catheterization | 1 | 2018 | 175 | 0.140 |
Why?
| | Mice | 9 | 2021 | 16937 | 0.140 |
Why?
| | Multidetector Computed Tomography | 1 | 2017 | 33 | 0.140 |
Why?
| | Administration, Oral | 2 | 2018 | 785 | 0.140 |
Why?
| | Population Surveillance | 1 | 2020 | 436 | 0.140 |
Why?
| | Tracheostomy | 1 | 2019 | 120 | 0.140 |
Why?
| | Terminally Ill | 1 | 2017 | 35 | 0.140 |
Why?
| | Nicorandil | 3 | 2021 | 11 | 0.140 |
Why?
| | Job Satisfaction | 2 | 2016 | 201 | 0.140 |
Why?
| | Prosthesis Design | 1 | 2019 | 306 | 0.140 |
Why?
| | Neuroprotection | 1 | 2017 | 38 | 0.140 |
Why?
| | STAT3 Transcription Factor | 1 | 2018 | 195 | 0.130 |
Why?
| | Neuroprotective Agents | 1 | 2018 | 122 | 0.130 |
Why?
| | Defibrillators, Implantable | 1 | 2020 | 297 | 0.130 |
Why?
| | Regional Blood Flow | 2 | 2019 | 462 | 0.130 |
Why?
| | Mitral Valve Insufficiency | 1 | 2017 | 67 | 0.130 |
Why?
| | Lung Transplantation | 1 | 2019 | 289 | 0.130 |
Why?
| | Coronary Vessels | 1 | 2018 | 241 | 0.130 |
Why?
| | Respiration, Artificial | 1 | 2020 | 609 | 0.130 |
Why?
| | Aneurysm, Infected | 1 | 2015 | 4 | 0.120 |
Why?
| | Heart Failure | 2 | 2019 | 2148 | 0.120 |
Why?
| | Pneumonia, Viral | 1 | 2020 | 340 | 0.120 |
Why?
| | Thrombosis | 1 | 2019 | 343 | 0.120 |
Why?
| | Coronavirus Infections | 1 | 2020 | 334 | 0.120 |
Why?
| | Fibrosis | 1 | 2018 | 520 | 0.120 |
Why?
| | Imaging, Three-Dimensional | 1 | 2019 | 530 | 0.120 |
Why?
| | Clinical Competence | 3 | 2020 | 1012 | 0.120 |
Why?
| | Sensitivity and Specificity | 1 | 2020 | 1835 | 0.120 |
Why?
| | Predictive Value of Tests | 1 | 2020 | 1945 | 0.110 |
Why?
| | Renal Circulation | 1 | 2014 | 57 | 0.110 |
Why?
| | Blood Vessel Prosthesis | 3 | 2022 | 124 | 0.110 |
Why?
| | Mitochondria | 1 | 2020 | 877 | 0.110 |
Why?
| | Echocardiography | 1 | 2017 | 628 | 0.110 |
Why?
| | Logistic Models | 2 | 2019 | 1986 | 0.110 |
Why?
| | Chi-Square Distribution | 1 | 2014 | 515 | 0.110 |
Why?
| | Cohort Studies | 5 | 2025 | 5414 | 0.100 |
Why?
| | Biomarkers | 2 | 2025 | 3972 | 0.100 |
Why?
| | Pulmonary Disease, Chronic Obstructive | 1 | 2020 | 982 | 0.100 |
Why?
| | Animals | 9 | 2021 | 35351 | 0.100 |
Why?
| | Perception | 1 | 2015 | 338 | 0.100 |
Why?
| | Renal Insufficiency | 1 | 2014 | 149 | 0.100 |
Why?
| | Smoking | 1 | 2019 | 1501 | 0.100 |
Why?
| | Societies, Medical | 1 | 2016 | 747 | 0.100 |
Why?
| | Body Mass Index | 1 | 2020 | 2270 | 0.100 |
Why?
| | Odds Ratio | 1 | 2014 | 1023 | 0.090 |
Why?
| | Chronic Disease | 1 | 2017 | 1713 | 0.090 |
Why?
| | Hypertension | 1 | 2020 | 1241 | 0.090 |
Why?
| | Analgesics, Opioid | 1 | 2019 | 913 | 0.090 |
Why?
| | Up-Regulation | 3 | 2018 | 840 | 0.090 |
Why?
| | Diabetes Mellitus | 1 | 2019 | 999 | 0.090 |
Why?
| | Severity of Illness Index | 2 | 2016 | 2737 | 0.090 |
Why?
| | Learning | 1 | 2015 | 400 | 0.090 |
Why?
| | Decision Making | 1 | 2017 | 849 | 0.090 |
Why?
| | Renal Dialysis | 1 | 2014 | 423 | 0.090 |
Why?
| | Survival Analysis | 3 | 2019 | 1272 | 0.080 |
Why?
| | Cells, Cultured | 1 | 2017 | 4082 | 0.080 |
Why?
| | Apoptosis | 1 | 2018 | 2503 | 0.080 |
Why?
| | Disease Models, Animal | 4 | 2021 | 4063 | 0.080 |
Why?
| | Sigmoid Diseases | 1 | 2009 | 10 | 0.080 |
Why?
| | Diverticulitis | 1 | 2009 | 8 | 0.080 |
Why?
| | Colostomy | 1 | 2009 | 26 | 0.080 |
Why?
| | Intestinal Perforation | 1 | 2009 | 45 | 0.080 |
Why?
| | Colectomy | 1 | 2009 | 94 | 0.070 |
Why?
| | Kidney Transplantation | 1 | 2014 | 672 | 0.070 |
Why?
| | Brain | 1 | 2020 | 2679 | 0.070 |
Why?
| | Operative Time | 2 | 2019 | 122 | 0.070 |
Why?
| | Young Adult | 3 | 2020 | 12416 | 0.070 |
Why?
| | Aortography | 2 | 2019 | 51 | 0.070 |
Why?
| | Physicians | 1 | 2015 | 864 | 0.070 |
Why?
| | Cross-Sectional Studies | 1 | 2016 | 5061 | 0.060 |
Why?
| | Laparoscopy | 1 | 2009 | 451 | 0.060 |
Why?
| | Quality of Life | 1 | 2016 | 2695 | 0.060 |
Why?
| | Organ Preservation | 1 | 2023 | 94 | 0.050 |
Why?
| | Aged, 80 and over | 1 | 2014 | 7069 | 0.050 |
Why?
| | Monitoring, Intraoperative | 1 | 2021 | 45 | 0.050 |
Why?
| | Signal Transduction | 3 | 2020 | 4925 | 0.050 |
Why?
| | Death | 1 | 2022 | 121 | 0.050 |
Why?
| | KATP Channels | 1 | 2021 | 20 | 0.040 |
Why?
| | Potassium Channels | 1 | 2021 | 149 | 0.040 |
Why?
| | Resource Allocation | 1 | 2020 | 39 | 0.040 |
Why?
| | Surgical Instruments | 1 | 2020 | 50 | 0.040 |
Why?
| | Suture Techniques | 1 | 2020 | 118 | 0.040 |
Why?
| | Collateral Circulation | 1 | 2019 | 18 | 0.040 |
Why?
| | Adenosine Triphosphate | 1 | 2021 | 480 | 0.040 |
Why?
| | Time-to-Treatment | 1 | 2020 | 180 | 0.040 |
Why?
| | Axillary Artery | 1 | 2018 | 12 | 0.040 |
Why?
| | Brachiocephalic Trunk | 1 | 2018 | 11 | 0.040 |
Why?
| | Echocardiography, Transesophageal | 1 | 2019 | 91 | 0.040 |
Why?
| | Glucose | 1 | 2023 | 1003 | 0.040 |
Why?
| | Constriction, Pathologic | 1 | 2019 | 228 | 0.040 |
Why?
| | Linear Models | 1 | 2020 | 819 | 0.040 |
Why?
| | Disease Progression | 2 | 2016 | 2626 | 0.040 |
Why?
| | Drug Synergism | 1 | 2018 | 371 | 0.040 |
Why?
| | Postoperative Care | 1 | 2019 | 238 | 0.030 |
Why?
| | Adolescent | 3 | 2023 | 20378 | 0.030 |
Why?
| | Vasodilator Agents | 1 | 2018 | 326 | 0.030 |
Why?
| | Sternotomy | 1 | 2016 | 25 | 0.030 |
Why?
| | Myocardial Ischemia | 1 | 2018 | 257 | 0.030 |
Why?
| | Thoracoscopy | 1 | 2016 | 52 | 0.030 |
Why?
| | Nitric Oxide | 1 | 2021 | 901 | 0.030 |
Why?
| | Professional Autonomy | 1 | 2016 | 29 | 0.030 |
Why?
| | Analysis of Variance | 1 | 2019 | 1287 | 0.030 |
Why?
| | Blotting, Western | 1 | 2018 | 1205 | 0.030 |
Why?
| | Patient Safety | 1 | 2019 | 286 | 0.030 |
Why?
| | Dilatation, Pathologic | 1 | 2015 | 60 | 0.030 |
Why?
| | Ohio | 1 | 2015 | 152 | 0.030 |
Why?
| | Recombinant Proteins | 1 | 2018 | 1304 | 0.030 |
Why?
| | Ventricular Function, Left | 1 | 2018 | 526 | 0.030 |
Why?
| | Heart | 1 | 2018 | 637 | 0.030 |
Why?
| | Phosphorylation | 1 | 2018 | 1713 | 0.030 |
Why?
| | Clinical Decision-Making | 1 | 2017 | 302 | 0.030 |
Why?
| | Employment | 1 | 2015 | 167 | 0.030 |
Why?
| | Forecasting | 1 | 2015 | 358 | 0.030 |
Why?
| | Insulin | 1 | 2023 | 2325 | 0.030 |
Why?
| | Recovery of Function | 1 | 2017 | 642 | 0.030 |
Why?
| | Pandemics | 1 | 2020 | 1482 | 0.020 |
Why?
| | Surgical Staplers | 1 | 2009 | 4 | 0.020 |
Why?
| | Surgical Stomas | 1 | 2009 | 7 | 0.020 |
Why?
| | Fat Necrosis | 1 | 2009 | 8 | 0.020 |
Why?
| | Intraoperative Period | 1 | 2009 | 53 | 0.020 |
Why?
| | Blood Loss, Surgical | 1 | 2009 | 92 | 0.020 |
Why?
| | Tomography, X-Ray Computed | 1 | 2015 | 2528 | 0.020 |
Why?
| | Feasibility Studies | 1 | 2009 | 865 | 0.010 |
Why?
|
|
Aftab's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|